Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Xanthine phosphodiesterase V inhibitors

Xanthine phosphodiesterase V inhibitors

US Patent 7531544 · Granted May 12, 2009

Estimated economic value: $208,740,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystal form of aromatic vinyl derivatives, and preparation method therefor and 2025
Processes and intermediates for the preparation of soluble guanylate cyclase sti2025
Processes and intermediates for the preparation of soluble guanylate cyclase sti2024
Pyridinone- and pyridazinone-based compounds and uses thereof2024
Processes and intermediates for the preparation of soluble guanylate cyclase sti2023
Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, interm2022
Salt of fused ring pyrimidine compound, crystal form thereof and preparation met2022
Processes and intermediates for the preparation of soluble guanylate cyclase sti2022
Aromatic acetylene or aromatic ethylene compound, intermediate, preparation meth2021
Aminopyrimidine five-membered heterocyclic compound, and intermediate, preparati2021
2,2-difluorodioxolo A2A receptor antagonists2021
Compounds inhibiting leucine-rich repeat kinase enzyme activity2021